Charlie Mata, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6350 Nw 37th Ter, Virginia Gardens, FL 33166 Phone: 305-469-6836 |
James A Martin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6501 Nw 36th St, Ste 307, Virginia Gardens, FL 33166 Phone: 305-871-3534 |
News Archive
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
The Palmetto Health Board of Directors has unanimously approved the establishment of Palmetto Health Quality Collaborative, LLC, often referred to as an accountable care organization. The Quality Collaborative will be a physician-led, patient-centered, interdependent medical entity that focuses on best practices in clinical outcomes and evidence-based care. Palmetto Health will soon begin offering the more than 1,000 physicians on its medical staff an opportunity to join.
Transplant: A Gift for Life - a one-hour, Emmy Award-winning PBS documentary that includes Mayo Clinic transplant patients, their families, and doctors - will be distributed to public television stations nationwide this month. On Nov. 8, more than 60 PBS stations will air the program simultaneously through the PBS World channel, and many other PBS stations will air the program at various times (check local listings) over the next three years.
Health and Human Services Secretary Kathleen Sebelius announced enrollment numbers today for the federal and state online health insurance marketplaces that opened Oct. 1. Medicaid enrollment data were also released.
Beiersdorf and Insilico Medicine, an artificial intelligence company developing end to end drug discovery pipelines, announced today that they are entering a collaboration to jointly discover novel, safe bioactive ingredients for a specific skin indication at an unparalleled pace, that will serve as the basis for developing appropriate skincare products.
› Verified 9 days ago